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Abstract
Background: Functional annotations are available only for a very small fraction of microRNAs (miRNAs) and very
few miRNA target genes are experimentally validated. Therefore, functional analysis of miRNA clusters has typically
relied on computational target gene prediction followed by Gene Ontology and/or pathway analysis. These
previous methods share the limitation that they do not consider the many-to-many-to-many tri-partite network
topology between miRNAs, target genes, and functional annotations. Moreover, the highly false-positive nature of
sequence-based target prediction algorithms causes propagation of annotation errors throughout the tri-partite
network.
Results: A new conceptual framework is proposed for functional analysis of miRNA clusters, which extends the
conventional target gene-centric approaches to a more generalized tri-partite space. Under this framework, we
construct miRNA-, target link-, and target gene-centric computational measures incorporating the whole tri-partite
network topology. Each of these methods and all their possible combinations are evaluated on publicly available
miRNA clusters and with a wide range of variations for miRNA-target gene relations. We find that the miRNA-
centric measures outperform others in terms of the average specificity and functional homogeneity of the GO
terms significantly enriched for each miRNA cluster.
Conclusions: We propose novel miRNA-centric functional enrichment measures in a conceptual framework that
connects the spaces of miRNAs, genes, and GO terms in a unified way. Our comprehensive evaluation result
demonstrates that functional enrichment analysis of co-expressed and differentially expressed miRNA clusters can
substantially benefit from the proposed miRNA-centric approaches.
Background
MicroRNAs (miRNAs) are short single stranded, non-
coding RNAs that regulate protein-coding mRNAs [1-4].
Mature miRNAs cause either target mRNA degradation or
translational repression [4] by inducing cleavage or inhibit-
ing translation in the 3’-untranslated regions (UTRs) of the
target mRNA [2,3]. In spite of the continuous attempts to
identify miRNAs and to elucidate their basic mechanisms
of action, little is understood about their biological
functions.
Because of the regulatory role of miRNAs [5] and lack of
direct functional annotation to miRNAs, current functional
enrichment methods for miRNAs rely instead on their tar-
get genes’ functional annotations [6-8]. If the target genes
of a specific miRNA are significantly enriched with a set of
Gene Ontology (GO) terms, it is reasonable to infer that
the miRNA is also involved in the same GO annotations.
As only few experimentally validated targets are available,
current methods of target gene’s annotation-based
* Correspondence: juhan@snu.ac.kr
1Seoul National University Biomedical Informatics (SNUBI) and Systems
Biomedical Informatics Research Center, Div. of Biomedical Informatics, Seoul
National University College of Medicine, Seoul 110799, Korea
Full list of author information is available at the end of the article
Lee et al. BMC Genomics 2012, 13(Suppl 7):S17
http://www.biomedcentral.com/1471-2164/13/S7/S17
© 2012 Lee et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
inference of miRNA function rely on target prediction
algorithms such as TargetScan [9,10] and Pictar [11].
Many studies on miRNAs have used this “predicted tar-
get-genes’ functional annotation-based” miRNA function
prediction strategy. Gaidatzis et al. [12] applied a log-
likelihood test for functional enrichment analysis for
KEGG pathways. Gusev [13] used hypergeometric distri-
butions for GO and pathway-based enrichment analysis.
Xu and Wong [14] applied hypergeometric distribution
test to detect significant over-representation of miRNA
cluster targets in BioCarta pathways. Similar methods
using GO, KEGG and BioCarta pathways were imple-
mented in miRGator [15] and SigTerms [16], applying
hypergeometric distributions to evaluate functional
enrichment.
The target links from miRNAs to genes, however, show
very uneven distributions. So do the links from genes to
GO terms. One miRNA may regulate more than several
hundreds of targets and one gene may be controlled by
many miRNAs [17]. In contrast, the current methods that
rely only on the predicted target genes’ functional annota-
tions are not powerful enough to capture such variability.
For instance, if a certain miRNA targeting hundreds of
genes is shared by different miRNA clusters, the clusters’
functional annotations may become very similar even
though they consist of very different miRNA members,
just because they share the ‘very bush’ one. Another lim-
itation of the current methods is that they treat all target
genes equally. One should differently weight genes that
are targeted by only one member from those that are tar-
geted by all members of a miRNA cluster. In summary,
the current functional enrichment methods for miRNA
cluster have limitations of not considering the tri-partite
network topologies from miRNAs to genes to functional
annotations regarding multiplicity and cooperativity, con-
taining more information than simple target gene counts.
For the purpose of illustration, Figure 1(A) and 1(B)
exhibit example cases where the same numbers of miR-
NAs (k = 5) from equal-sized clusters (k = 6) are targeting
the same numbers of target genes (k = 6) from equal num-
ber of genes (k = 11) that are annotated to a specific GO
term, GO:0030282 and GO:0051482, respectively. The
numbers of target links between Figure 1(A) and 1(B),
however, are differently 8 and 22, respectively. Figure 1(C)
and 1(D) exhibit cases where the numbers of miRNAs
connected to a specific GO term, GO:0015917 and
GO:0030851, are differently 6 and 3, respectively, while
the numbers of links (k = 6) are the same. It is clearly
demonstrated that the current approach only based on tar-
get gene counts is unable to discern the difference in these
targeting relations.
The present study proposes a more generalized concep-
tual framework to develop and analyze new functional
enrichment measures. According to the framework, the
traditional “predicted target-genes’ functional annotation-
based” miRNA function prediction method is regarded as
‘target gene-centric’ denoted by r because it eventually
considers only the fraction of the target genes among
those that are annotated to a specific GO. Under the pro-
posed framework, we derive ‘target link-centric’ (τ) and
‘miRNA-centric’ (μ) measures, considering the numbers of
links and miRNAs linked to a specific GO term.
Figure 1 illustrates that while the traditional target gene-
centric r measure cannot discern (A) and (B) (p =
0.30325) nor (C) and (D) (p = 0.31120), the newly pro-
posed τ and μ measures successfully discern (A) and (B) (i.
e., p = 0.62358 and p = 0.00956, respectively) and (C) and
(D) (i.e., p = 0.00695 and p = 0.65253, respectively). It is
clearly demonstrated that different measures calculated
from different viewpoints significantly impact the result of
functional enrichment analysis of miRNA clusters. We
also propose a rank statistic for the purpose of systematic
comparison in terms of the average specificity and func-
tional homogeneity of the significantly enriched term for
each GO category, Biological Process (BP), Molecular
Functions (MF), and Cellular Components (CC). We show
that the proposed miRNA-centric measures identify more
specific and functionally homogenous sets of GO annota-
tions for miRNA clusters.
Methods
Dataset: miRNA clusters
We used publicly available co-expressed and differentially
expressed miRNA clusters for comparative evaluation of
the proposed methods. For co-expressed miRNA clusters,
we obtained the data created by Ruepp et al. [18] that
show correlated expression patterns across several human
diseases. The data can be downloaded from Ruepp et al.
[18] (http://genomebiology.com/content/supplementary/
gb-2010-11-1-r6-s2.xls). Forty three among the 47 clusters
having at least one target gene were used in this study.
Differentially expressed miRNA sets consisting of up- or
down-regulated genes in six solid tumors were also down-
loaded [19]. MiRNAs down-regulated in colon cancer had
no target gene and hence were excluded in the present
study. Supplement Tables S1 and S2 in ‘Additional file 1’
list the 54 (= 43 + (2 × 6) - 1) miRNA clusters from the
two studies with the associated information.
Creating variations of miRNA-mRNA target pairs for
comprehensive evaluation
Another input of our analysis is the target gene list of each
miRNA that will guide the functional enrichment test
based on the gene annotations. Considering that only a
few experimentally validated miRNA targets are available,
we use miRNA-mRNA target pairs obtained from compu-
tational target prediction methods. Prediction algorithms
generate a relatively high level of false positives [20] and
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the degree of overlap between predicted targets from dif-
ferent methods is often poor or null [21]. Given the lack
of ‘gold standard’ for miRNA and target gene pairs, we
consider a wide range of variations in miRNA-gene pair
relations for comprehensive evaluation. We used miRe-
cords [22] and miRGen [23], which are integrated
resources of miRNA-target interactions from 11 estab-
lished target prediction algorithms and from four most
Figure 1 Indiscernibility example. Calculating target gene-centric (r) hypergeometric distribution cannot discern the completely different
targeting topologies between (A) and (B) and between (C) and (D), resulting the same p-values (p = 0.30325 and 0.31120), respectively. The
target link-centric (τ p-values can discriminate (A) and (B) (i.e., p = 0.62358 and 0.00956, respectively) and the miRNA-centric (μ p-values can
discriminate (C) and (D) (i.e., p = 0.00695 and 0.65253, respectively). *p < 0.05, hypergeometric test.
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widely used target prediction programs, respectively. We
created 21 variations for predicted target pairs by consid-
ering the number of positive voters from the included
algorithms by miRecords (Table 1, upper panel) and six
variations by applying the four programs of miRGen
(Table 1, lower panel). Because most of the evaluation
results from these variations were largely comparable, the
most representative variation #6 in Table 1 was used to
describe the overall study results in the following sections.
Variation #6 was created by applying the 11 algorithms
provided by miRecords, wining more than three positive
voters and resulting in 1,569,741 target links from 553
miRNAs to 17,636 genes. As the number of required posi-
tive voters is increasing, the numbers of miRNAs, links
and genes are decreasing as can be seen in Table 1.
Target gene-, target relation-, and miRNA-centric
calculations of hypergeometric distributions
Now we describe the details of the proposed measures
in a proposed conceptual framework. Suppose we want
to test the functional enrichment of a miRNA cluster
with respect to a specific GO term (or annotation).
In most previous approaches, one first constructs a cor-
responding target gene cluster consisting of all the
genes targeted by at least one member in the miRNA
cluster. Then the numbers of target genes annotated (ri)
and not annotated (rj) by the GO term are used in the
two by two contingency table along with the numbers of
genes not in the target cluster and are either annotated
(rk) or not annotated (rl) with the term, as shown in
Figure 2(B). Functional enrichment is tested from this
contingency table using a hypergeometric distribution.
These traditional target gene-centric (r) methods are
limited in that they consider only the fraction of target
genes connected to a specific annotation for each anno-
tation [12-14], as already illustrated in Figure 1. To this
rather confusing problem, the diagram and contingency
tables in Figure 2 provide a conceptual framework to
understand and correctly design new functional enrich-
ment measures. The diagram of miRNA, gene and
Table 1 Variation for predicted miRNA-gene target pairs
Index No. of algorithms showing positive voting Numbers of
miRNAs Target links Genes
miRecords (Xiao et al., 2009)
#1 3 algorithms 553 1,234,390 17,602
#2 4 535 272,505 15,278
#3 5 407 53,041 9,747
#4 6 159 9,691 2,783
#5 7 29 68 66
#6 3 ~ 11 553 1,569,741 17,636
#7 4 ~ 11 535 335,351 15,422
#8 5 ~ 11 408 62,846 9,851
#9 6 ~ 11 159 9,805 2,816
#10 7 ~ 11 40 114 104
#11 3 ~ 11 including DIANA-microT 0 0 0
#12 3 ~ 11 including Microinspector 56 184 160
#13 3 ~ 11 including miRanda 552 1,416,379 17,584
#14 3 ~ 11 including mirtarget2 530 184,544 13,841
#15 3 ~ 11 including miTarget 0 0 0
#16 3 ~ 11 including NBmiRTar 42 201 172
#17 3 ~ 11 including PicTar 163 64,658 6,515
#18 3 ~ 11 including pita 551 1,559,586 16,676
#19 3 ~ 11 including rna22 54 232 197
#20 3 ~ 11 including rnahybrid 552 1,548,423 17,630
#21 3 ~ 11 including TargetScan 412 343,190 16,127
miRGen [23]
#22 DIANA-microT 175 1,816 1,206
#23 miRanda (microrna.org) 469 430,878 16,699
#24 miRanda (miRBase) 156 38,821 5,444
#25 PicTar (4-way) 177 68,100 6,391
#26 PicTar (5-way) 128 22,028 2,433
#27 TargetScanS 237 75,044 7,546
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annotation worlds in Figure 2(A) depicts the tri-partite
network topology between the three worlds such that
one can drive the quartet numbers to create contingency
tables for miRNA-centric (τ) and target link-centric (μ)
as well as for the target gene-centric (r) measures
(Figure 2(B)~(D)).
Under this conceptual framework in Figure 2, sub-
scripts i and k represent positive and subscripts j and l
negative connections to the GO term. Subscripts i and j
represents connections from inside of and k and l from
outside of the targeting miRNA or target gene clusters.
The traditional ri and rj, for example, correspond to the
sets of target genes that are annotated (ri) and not
annotated (rj) to a specific GO term. rk and rl denote
non-targeted genes that are annotated (rk) and not
annotated (rl) to the GO term. We can develop a
miRNA-centric measure in the conceptualized three fra-
mework in a consistent way. We define μi and μj as the
miRNAs in the cluster whose target genes are annotated
(μi) and not annotated (μj) to the GO term. As in the
case of a gene-centric measure, μk and μl correspond to
miRNAs outside of the cluster whose target genes are
annotated (μk) and not annotated (μk) to the GO term.
Similarly, for a target link-centric measure, we define τi
and τj as the target links connecting members of the
miRNA cluster in μi and in μj, respectively, to genes
that are connected (ri) and not connected (rj) to a spe-
cific GO term. Remaining miRNAs outside the cluster,
μk and μl, target genes through τk and τl that are headed
to genes that are connected (rk) and not connected (rl)
to the GO term.
To formally define the three measures, let r, τ, and μ
be the random variables that represent the number of
target genes, target links, miRNAs, respectively, which
are linked to a specific GO term as explained above.
The following three equations, (1), (2), and (3),
describe the hypergeometric distributions of r, τ, and
μ, respectively.
Figure 2 Framework for developing three types of miRNA functional enrichment measures. A conceptual framework is constructed to
consider the tri-partite network topology. (A) A miRNA cluster under investigation contains the members, μi and μj, targeting genes that are
associated (ri) and not associated (rj) with a specific GO term of interest through τi and τj, respectively. Non-member miRNAs may be associated
(μk®rk) or not (μl®rl) with the GO term through τk and τl. Counts for (D) miRNA-centric (μ) and (C) target link-centric (τ) as well as (B) target
gene-centric (r) are listed by two-by-two contingency tables. The closed and broken circles in the miRNA world depict the miRNA cluster under
investigation and the subset miRNAs targeting the genes that are associated with a specific GO term of interest.
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Note that for notational convenience, we now used ra,
τa, μa for a Î {i, j, k, l}, instead of |ra|, etc., to represent
the number of members in the corresponding set by
abuse of notation. The p-value for the enrichment test
from hypergeometric distribution of the random variable
r is calculated from the cumulative probability of obser-
ving at least ri out of ri + rj times. Accordingly, the
p-value from each of the three measures can be defined
as follows;
p − valueρ = probability(ρ ≥ ρi)
p − valueτ = probability(τ ≥ τi)
p − valueμ = probability(μ ≥ μi)
These probabilities are computed using the phyper
and dhyper functions in R ‘stats’ package.
Combining P-values
For the purpose of comprehensive evaluation, we create all
possible combinations of the three measures and tested
each of those at all GO categories and using different
miRNA-target gene pair sets. Figure 3 illustrates steps of
combining the three types of hypergeometric distributions
for r, τ and μ. For each of the 54 miRNA clusters, of the
27 variations for miRNA-target gene pairs, of the three
GO categories, and of annotations (or GO terms), three
p-values, pr, pτ and pμ, are first computed. Then, we gen-
erate 4 combined p-values by using Fisher’s combined
p-value method [24].
pρ,τ : combined p - value of pρ and pτ
pρ,μ : combined p - value of pρ and pμ
pτ ,μ : combined p - value of pτ and pμ
pρ,τ ,μ : combined p - value of pρ , pτ and pμ
We briefly describe how Fisher’s combined p-value
method can be applied to our proposed measures.
Under the null hypothesis of no significant enrichment,
the individual p-value for the random variable r, τ, or μ
follows the uniform distribution on 0[1]. Then the dis-
tribution of
Y = −ln (p - value)
is chi-squared with one degree of freedom. We have
three p-values from r, τ, and μ hypergeometric distribu-
tions,
pρ,pτ and pμ,















Figure 3 Steps for combining three types of p-values. For a
selected GO category and a miRNA-gene target-pair variation, for
each GO term, three p-values are computed for r, τ, and μ, and
then rank normalized. Sr(n) denotes the set of GO terms whose p-
values’ ranks in the r hypergeometric distribution are less than or
equal to n. By applying set operations, four combinations of Sr(n),
Sτ(n), Sμ(n) are created for further evaluation.
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Each of the random variables Yr, Yτ, and Yμ is under
the chi-squared distribution with one degree of freedom.
The final four sums of W are then defined as follows:
W1 = Yρ + Yτ
W2 = Yρ + Yμ
W3 = Yτ + Yμ
W4 = Yρ + Yτ + Yμ
The random variables W1, ..., W4 follow chi-squared dis-
tribution with degrees of freedom 2, 2, 2, and 3, respec-
tively. These random variables are used to produce the
combined ‘overall’ p-values. To calculate these p-values, we
applied fisherSum function in R ‘MADAM’ package [25].
The underlying distribution of p-values from each
method can be different due to the different characteris-
tics of the measure. To take into account this heteroge-
neity in the distribution of p-values, we rank-normalized
p-values for each GO category as shown in the last step
of Figure 3. Specifically, we construct the set Sθ(n) of top
n significant GO terms having the smallest p-values for
each measure θ Î {r, τ, μ}. Four additional sets of Sr,τ(n),
Sr,μ(n), Sτ,μ(n), and Sr,τ,μ(n) for the combined measures
are also created and used for further evaluation.
Evaluation measures
Average specificities and functional homogeneity index
(or semantic similarity density) of the rank normalized
term sets Sθ(n) for each measure θ Î{r, τ, μ,(r, τ), (r, μ),
(τ, μ), (r, τ, μ)} are computed for performance compari-
son. This is based on the general assumption that for a
specific set of GO terms identified by each measure, the
more functionally homogenous the set is, the more reli-
able the measure is. In addition, higher specificities are
more desirable because it is more informative to have
more specific terms than more general terms in the
functional analysis of clusters.
Many studies have shown that Information Content
(IC) can quantify the specificity of a cluster [26,27]. IC
measure is based on the fact that less frequently used
terms are more specific. The IC of a GO term t is
defined as follows:






where root represents the root term for each GO cate-
gory. freq(t) is defined as follows;
freq (t) = n (annotate (t)) +
∑
c∈children(t)
n (annotate (c)) (5)
where children(t) returns the list of child terms of
term t. Thus t becomes a parent term of all members of
children t), either directly or indirectly. The functions
annotate(t) and n(G) return the list of genes that are
annotated to GO term t and the number of the genes in
the gene list G, respectively. We use the average IC
value of the given term set as a performance measure to
compare the specificity.
For functional homogeneity index (or semantic similar-
ity density), we choose a widely used Resnik’s measure of
semantic similarity [28]. The semantic similarity between
two terms is defined as the IC of the lowest common
ancestor (LCA) of the two terms and hence is obtained by:
SResnik (tA, tB) = IC (LCA (tA, tB)) (6)
As an evaluation measure, the average of all pairwise
term-to-term Resnik’s similarities was applied for Sθ(n)
for each measure θ Î {r, τ, μ, (r, τ), (r, μ), (τ, μ), (r, τ, μ)}
and defined as semantic similarity density of the set.
GO terms and associated gene sets were downloaded
from http://www.geneontology.org/gene-associations/
gene_association.goa_human.gz. We excluded GO asso-
ciations having ND (No biological data) or NR (Not
Recorded) evidence codes.
Results
Average specificity and functional homogeneity index
distributions
Figure 4 shows the distributions of average IC values and
functional homogeneity index for GO BP terms with p-
values in top n = 100 ranks in the ‘breast/up-regulated
miRNA cluster’ from Volinia et al. [19] (Supplementary
Table S2 in ‘Additional file 1’). Most of the highest aver-
age IC and functional homogeneity values were obtained
by miRNA-centric μ measures throughout the evalua-
tions (see Supplement Fig. S1 series in ‘Additional file 1’)
including the specific example shown in Figure 4.
Because of the small numbers of miRNA members and
target genes, target variations #5, #10, #11, #15, and #16
in Table 1 had no significant GO terms. Evaluation
showed that miRNA-centric μ measure exhibited the best
specificity and homogeneity except only for the target
variations #12, #19 and #22. The very small numbers of
miRNAs (i.e., m = 56, 54, 175, respectively) and target
genes (i.e., m = 160, 197, 1206, respectively) from the
very strict thresholds may explain the results. These find-
ings are also consistent throughout the evaluation study
regardless of different GO categories.
Performance comparison with a varying parameter
setting
Figure 5(A) and 5(B) shows the distributions of the
average IC values and functional homogeneity values
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Figure 4 Evaluation of functional enrichment measures and their combinations. Distributions of (A) functional homogeneity index (or
average IC value) and (B) semantic similarity (or average all pair-wise Resnik’s similarity) are exhibited for significantly enriched GO BP terms in
the ‘breast/up-regulated miRNA cluster’ from Volinia et al. [19](see index 1 in Supplement Table S2) by applying target variation #6 in Table 1.
MicroRNA-centric measure (μ) outperforms the traditional target gene-centric measure (r) and others.
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Figure 5 Evaluation of functional homogeneity and semantic similarity densities across different thresholds. Average (A) information
content and (B) all pair-wise semantic similarity values are plotted with increasing numbers of rank normalized GO terms n (see Fig. 3) for
“breast/up-regulated miRNA cluster” from Volinia et al. [19] (index 1 in Supplementary Table S1 in ‘Additional file 1’) by applying target variation
#6 in Table 1, GO BP category. Measures containing miRNA-centric μ (in blue) like (r, μ) (in pink) and (τ, μ) (in sky blue) consistently outperform
traditional gene-centric r (in red) measures at all levels.
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with increasing numbers of rank normalized GO terms
n (see Figure 3), as an example for “breast/up-regulated
miRNA cluster” from Volinia et al. [19] (index 1 in
Supplementary Table S1 in ‘Additional file 1’) by apply-
ing target variation #6 in Table 1, GO BP category.
Measures containing miRNA-centric μ (in blue cross)
like (r, μ) and (τ, μ) consistently outperformed tradi-
tional gene-centric r (in red circle) at all threshold levels
of n. Figure 6 demonstrates the distribution of p-values
for all GO BP terms annotated to the miRNA clusters
from the dataset of Volinia et al. [19]. Although the
interpretation about the p-value distribution is generally
tricky and needs to be done carefully, it seems that the
p-value distribution for miRNA-centric μ (in green)
shows overall better discriminant power than target
link-centric τ (in blue) and traditional gene-centric r (in
red) methods.
Examples showing complementary properties
Examples of GO terms determined to be statistically sig-
nificant by miRNA-centric μ but not by traditional gene-
centric r method are listed in the upper part of Table 2.
Gusev [13] correctly pointed out that it was common for
top ranked GO terms to be targeted by every member of
the corresponding miRNA cluster. Those that are tar-
geted by all six miRNA members (i.e., μi = 6) shown in
the upper part of Table 2, however, are not statistically
significant (p > 0.05) and show poor ranks (>290) by r
method. But μ method shows statistical significances (p <
0.05) with high ranks (<35) (Table 2). In contrast, those
that are targeted by all six miRNA members shown in
the middle part of Table 2 show very strong statistical
significance (p < 0.001) by r method. The very low μk to
μl ratios (i.e., about 50:1) in the middle part compared to
those in the upper part (i.e., about 1:1) of Table 2 clearly
explain the poor p-values and ranks (>2500) by μ
method. Therefore, Gusev’s correct intuition can further
be formally analyzed by introducing miRNA-centric μ
method. It is demonstrated that our new measure consid-
ering μ complements some drawbacks of the traditional
gene-centric r measure.
The GO terms in the lower part of Table 2 are anno-
tated only to two to five among six mRNA members
such that they are far from statistical significance by r
calculations. The p-values by μ method, however, are
even more statistically significant. Complement activation
(GO:0006956) in GO BP category was rejected by the tra-
ditional r method (p = 0.42) but accepted by miRNA-
centric μ method (p > 0.001) with ranks of 1251 and 1,
respectively. Complement activation indeed has long
been well recognized in breast cancer [29,30]. At least
four well-known breast cancer genes including SMAD2,
SMAD4, TGFB3 and TGFBR3 are involved in palate
development. There are many studies reporting that regu-
lation of growth hormone secretion (GO:0060123) is
indeed associated with breast cancer [31-33]. For the GO
term, negative regulation of activin receptor signaling
pathway (GO:0032926), many studies reported that
Figure 6 Distribution of p-values for all GO BP terms. Distribution of p-values for all GO BP terms demonstrates that miRNA-centric μ (in
green) shows overall better discriminant power than target link-centric τ (in blue) and traditional gene-centric r (in red) methods for datasets
from Volinia et al. [19].
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facilitating activin signaling either by Cripto silencing or
FLRG silencing inhibits human breast cancer cell growth
[34,35]. Numerous studies have reported that acetyl-CoA
carboxylase (ACCa) and fatty acid synthase (FAS), key
limiting fatty acid synthesis enzymes involved in coen-
zyme A metabolic process (GO:0015936), are highly
expressed in human breast cancer cell lines and breast
carcinomas [36-40]. Moreover, pantothenate kinase 3
(PANK3) and Coenzyme A synthase (COASY) are
known breast cancer genes.
Discussion
We proposed miRNA-centric μ and target link-centric τ
measures that improve functional enrichment analysis of
differentially expressed or co-expressed miRNA clusters.
We performed comprehensive evaluations of different
methods on various settings. It is demonstrated that these
new measures complement the conventional target gene-
centric r measure and miRNA-centric μ method was
among the most powerful and reliable.
MicroRNA’s intrinsic properties of multiplicity and
cooperativity [17] may be correctly modeled by combined
hypergeometric distributions. Average IC value for the μ
category was consistently the highest among different con-
ditions and measures. It is suggested that the number of
miRNAs and their relations associated with a specific GO
term of interest is as much important as the number of tar-
get mRNAs associated with the GO term. Therefore,
applying r, τ, and μ hypergeometric distributions for func-
tional annotation of miRNAs are mutually complementary.
The proposed method is based on computationally pre-
dicted rather than experimentally validated target rela-
tions. Computational prediction has limitations given high
level of false positives and negatives. Especially, it is diffi-
cult to obtain predicted targets for minor forms of miRNA
such as star, -3p, -5p or other recently identified forms of
miRNAs. All current computational enrichment analysis
methods that use predicted target relations suffer from the
same drawback. Combining the proposed three methods
may complement with each other in finding and evaluat-
ing the correct miRNA-mRNA target relations, and
improving functional annotations and enrichment analysis.
Additional material
Additional file 1: Supplementary Figures and Tables. This file
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